Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
about
Using magnetic resonance imaging to assess visual deficits: a reviewMagnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature3D GABA imaging with real-time motion correction, shim update and reacquisition of adiabatic spiral MRSIIn vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganeseAssessment of Anterior Cingulate Cortex (ACC) and Left Cerebellar Metabolism in Asperger's Syndrome with Proton Magnetic Resonance Spectroscopy (MRS)Decreased auditory GABA+ concentrations in presbycusis demonstrated by edited magnetic resonance spectroscopy.Neurochemical changes within human early blind occipital cortex.An update of the classical and novel methods used for measuring fast neurotransmitters during normal and brain altered functionMulti-regional investigation of the relationship between functional MRI blood oxygenation level dependent (BOLD) activation and GABA concentration.Spectral editing for in vivo ¹³C magnetic resonance spectroscopyMagnetic resonance spectroscopy studies of human metabolism.In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics.Field-frequency locked in vivo proton MRS on a whole-body spectrometer.Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABAMagnetic resonance spectroscopy of the human brain.Volume-localized two-dimensional correlated magnetic resonance spectroscopy of human breast cancer.Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate.A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.Brain proton magnetic resonance spectroscopy of alcohol use disorders.Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid–edited MR spectroscopy spectra.fMRI and MRS measures of neuroplasticity in the pharyngeal motor cortex.In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of conceptTissue correction for GABA-edited MRS: Considerations of voxel composition, tissue segmentation, and tissue relaxations.A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.Astrocytes convert network excitation to tonic inhibition of neuronsBrain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies.Brain γ-aminobutyric acid (GABA) detection in vivo with the J-editing (1) H MRS technique: a comprehensive methodological evaluation of sensitivity enhancement, macromolecule contamination and test-retest reliability.Prospective frequency correction for macromolecule-suppressed GABA editing at 3T.B0 magnetic field homogeneity and shimming for in vivo magnetic resonance spectroscopy.Brain imaging in nonhuman primates: insights into drug addiction.In vivo estimation of gamma-aminobutyric acid levels in the neonatal brain.Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.Proton magnetic resonance spectroscopy: an emerging technology in pediatric neurology research.Biological and clinical MRS at ultra-high field.In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders.Brain GABA editing without macromolecule contamination.Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS).Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.
P2860
Q26750521-806C7042-1911-484B-9584-3EFD2DA295C7Q27026039-7DD15069-FD31-4F95-ACD7-8EE16F18040DQ27307487-8CD7B3B3-2B6C-4731-BA6C-4EF161E08A33Q28386303-24BFF969-440D-41F7-970E-158915BA8334Q28468407-15ECB7FA-E4E1-4DF4-9F3D-2F01873AF5BAQ30392489-089CD3F2-29FE-425B-96B0-284AC7A3E0BFQ30408825-587F082E-E667-4EB2-8C80-F29C2A3C1627Q30410156-EE36C90B-4E81-4076-A7EF-B901475749DCQ30418128-80273A69-D293-4960-A67C-29C46239373CQ30459554-E307D697-CB37-4A4B-A9AF-6BE49F765444Q30467992-FDD66A6D-B995-45DC-9E0B-44D0B4BF7939Q30580994-0042DDC1-0103-47C2-8FC6-09A6F950B636Q30581992-302C0C49-BB56-4CBC-90C4-AFAABEA7AC13Q30582031-9FCD66CB-59A4-4AB4-8B98-A7EA093817ABQ30650759-1B98BE2C-D5EB-479F-9BA3-80186B8A8E38Q30657513-23AFB7C7-C081-4B5B-B35A-9804D11B323EQ30664676-738A1B34-EBD5-4AA6-8573-5E0196139C07Q30698264-F70C0132-EAF2-467E-905F-F8DB2D4DCDCAQ30859378-2E715583-7C2A-4AC9-B655-C1E2976BBD3BQ30882229-5B36698D-E746-40F0-9859-CF9032359F5DQ30952043-F8E8112C-B300-4D7A-9768-35659881DF36Q30976220-1FB95EAF-5409-4011-A54B-BED823EF3074Q30980247-00CD6FB5-DF5E-429E-9819-D32563E8E272Q30987882-7A158301-69F9-48E6-8295-4B3E5552158EQ30993265-5FA7B098-D701-499A-92DA-F10B79B7D564Q31032734-86CC0448-5FF7-485A-8CA1-2316E734CB93Q31051117-3AFFF495-1023-4E2E-9313-C2C4B5BDB8F5Q31090438-B68F72F1-F604-49A2-94DA-CE009D6E30DBQ31095683-066912AD-12CD-4624-833E-3758F66C1B72Q31103878-63BA0AD0-C756-40D2-AA1E-37A91E570FD9Q31107556-2DDD1A87-1AA7-4BC1-8E47-F41F3CD63954Q31141730-68E6A3AE-F1B3-4798-BC1D-FD2BFF77C6E1Q31143052-D183985E-F648-4805-8CB4-ED60BE24A213Q32027616-92FDE85C-9F4F-4181-AC4A-E97B7EA624D4Q32053186-4F8F2979-3243-4A81-939F-E08802026873Q32068002-EEBC35D9-0194-400C-9E22-E28D307CD9C5Q32115381-E2958A62-FD8B-44A0-A1E1-4E0F0D189C68Q32163102-865BF5A1-CAB5-430A-B7B6-4925DB401DC3Q33384845-907ACE6F-9627-4D44-A0C6-8779F010893DQ33389974-9DF4BC5D-7149-4357-8A09-5FBE9BF96A61
P2860
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
@ast
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
@en
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
@nl
type
label
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
@ast
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
@en
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
@nl
prefLabel
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
@ast
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
@en
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
@nl
P2093
P2860
P356
P1476
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
@en
P2093
D L Rothman
O A Petroff
R H Mattson
P2860
P304
P356
10.1073/PNAS.90.12.5662
P407
P577
1993-06-01T00:00:00Z